Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: E9B353
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0008794 | arsenate reductase (glutaredoxin) activity | 4 | 2 |
GO:0016491 | oxidoreductase activity | 2 | 2 |
GO:0030611 | arsenate reductase activity | 3 | 2 |
GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors | 3 | 2 |
GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 29 | 33 | PF00656 | 0.549 |
CLV_NRD_NRD_1 | 66 | 68 | PF00675 | 0.231 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.313 |
CLV_PCSK_SKI1_1 | 88 | 92 | PF00082 | 0.321 |
DOC_CYCLIN_RxL_1 | 58 | 66 | PF00134 | 0.526 |
DOC_MAPK_DCC_7 | 95 | 105 | PF00069 | 0.549 |
LIG_Actin_WH2_2 | 92 | 109 | PF00022 | 0.520 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.474 |
LIG_CtBP_PxDLS_1 | 9 | 13 | PF00389 | 0.490 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.526 |
LIG_LIR_Apic_2 | 5 | 9 | PF02991 | 0.427 |
LIG_LIR_Gen_1 | 53 | 64 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 111 | 117 | PF02991 | 0.499 |
LIG_LIR_Nem_3 | 53 | 59 | PF02991 | 0.478 |
LIG_NRBOX | 11 | 17 | PF00104 | 0.417 |
LIG_Pex14_1 | 110 | 114 | PF04695 | 0.526 |
LIG_Rb_LxCxE_1 | 45 | 65 | PF01857 | 0.482 |
LIG_SH2_PTP2 | 98 | 101 | PF00017 | 0.490 |
LIG_SH2_STAP1 | 56 | 60 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.350 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.492 |
LIG_SH3_3 | 77 | 83 | PF00018 | 0.379 |
LIG_SUMO_SIM_anti_2 | 10 | 17 | PF11976 | 0.461 |
LIG_SUMO_SIM_par_1 | 10 | 17 | PF11976 | 0.461 |
MOD_CK1_1 | 45 | 51 | PF00069 | 0.526 |
MOD_CK2_1 | 47 | 53 | PF00069 | 0.494 |
MOD_CK2_1 | 59 | 65 | PF00069 | 0.463 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.464 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.489 |
MOD_PKA_2 | 30 | 36 | PF00069 | 0.549 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.446 |
MOD_Plk_4 | 59 | 65 | PF00069 | 0.502 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.530 |
MOD_SUMO_for_1 | 7 | 10 | PF00179 | 0.408 |
MOD_SUMO_rev_2 | 65 | 70 | PF00179 | 0.526 |
TRG_DiLeu_BaEn_1 | 11 | 16 | PF01217 | 0.419 |
TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.475 |
TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.349 |
TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.499 |
TRG_Pf-PMV_PEXEL_1 | 61 | 65 | PF00026 | 0.294 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDD0 | Leptomonas seymouri | 71% | 100% |
A0A0S4IHU2 | Bodo saltans | 38% | 91% |
A0A1X0NRP2 | Trypanosomatidae | 46% | 86% |
A0A3Q8IGZ4 | Leishmania donovani | 90% | 100% |
A0A3R7KPC6 | Trypanosoma rangeli | 54% | 99% |
A4HKR5 | Leishmania braziliensis | 83% | 100% |
A4I895 | Leishmania infantum | 91% | 100% |
Q8WZK3 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 30% | 92% |
V5AXX4 | Trypanosoma cruzi | 55% | 100% |